Metformin

Active ingredient description

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Metformin
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BA Biguanides
Discover more medicines within A10BA02

Medicines

Metformin is the active ingredient of these drugs:

Drug
Countries

Poland

United Kingdom

Hong Kong

Hong Kong

South Africa

Cyprus Hong Kong Tunisia

Lithuania

Austria

Hong Kong Singapore South Africa

Austria

Australia

Tunisia

Tunisia

Poland

Australia Brazil Hong Kong South Africa

Tunisia

United Kingdom

Tunisia

Singapore

South Africa

Spain

South Africa

Hong Kong

Hong Kong New Zealand

Poland

South Africa

Australia Brazil Hong Kong Singapore

Lithuania Poland

Tunisia

South Africa

Brazil

United States

South Africa

Hong Kong

Brazil

Brazil

Brazil

Netherlands Singapore United Kingdom

Australia

Hong Kong

South Africa

Hong Kong Singapore

Austria Canada Cyprus Finland France

Tunisia

United Kingdom

Hong Kong

Hong Kong

Hong Kong

Canada United States

Singapore

Cyprus Singapore

Hong Kong

Hong Kong

Germany

Italy

Poland

Ireland

Hong Kong

Poland

Tunisia

Austria

Singapore United Kingdom

Poland

Hong Kong

South Africa

United Kingdom

South Africa

Poland

Australia

Germany Lithuania Poland

Italy

Cyprus Hong Kong Italy Lithuania Singapore

Finland

Poland

Poland

Hong Kong

Hong Kong

South Africa

South Africa

Hong Kong

Brazil

South Africa

United Kingdom

Brazil

Cyprus

Singapore

Finland

Hong Kong

Cyprus

United States

Hong Kong

Hong Kong

Germany Ireland Poland

Italy

Poland Tunisia

France Tunisia

United Kingdom

Poland

Brazil

Lithuania

Spain

United Kingdom

Poland

Italy

Metformin is also found within below combination drugs:

ACTOPLUS MET , ACTOSMET , AGARTHA DUO , AGNIS COMBI , AMARYL COMBI , AMARYL M , AVANDAMET , AZULIX MF , COMPETACT , DALTEX , DIAGLIMET , EBYMECT , EFFICIB , EPROCLIV , EUCREAS , GALVUMET , GALVUS MET , GALVUSMET , GLICONORM , GLICOREST , GLIPTAMET , GLITEX , GLIVANCE , GLUAMET , GLUBRAVA , GLUCOVANCE , ICANDRA , INVOKAMET , IPINZAN , JALRAMET , JANUMET , JARDIAMET , JARDIANCE DUO , JENTADUETO , JUZIMETTE , KAZANO , KOMBIGLYZE XR , KOMBOGLYZE , MAYMETSI , MELKART DUO , MERITOR , METSIGLETIC , NESINA MET , NIMEGON MET , PERNUVI COMBI , QTERNMET XR , QTRILMET , RISTFOR , SADEMLIP , SEGLUROMET , SITAVIA PLUS , SYKURZUKI , SYNJARDY , TRAJENTA DUO , TRAJENTAMET , TRAYENTA DUO , TRIJARDY XR , VELMETIA , VILDAGERLAN , VILDAMET , VILSPOX , VIMETSO , VIPDOMET , VOKANAMET , XIGDUO , ZOMARIST

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Structured Product Labeling (SPL/PLR)
US
Structured Product Labeling (SPL/PLR)
US
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

3D molecular structure

3D representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

9100L32L2N - METFORMIN

CAS registry number

1115-70-4 - Metformin hydrochloride

657-24-9 - metformin

SNOMED-CT

372567009 - Metformin (substance)